Laure Garrigue-Antar

Author PubWeight™ 13.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007 2.00
2 Bone morphogenetic protein-1 (BMP-1). Identification of the minimal domain structure for procollagen C-proteinase activity. J Biol Chem 2003 1.04
3 Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1). J Biol Chem 2005 1.03
4 The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha. J Mol Biol 2008 1.02
5 Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res 2009 1.01
6 The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer. Cancer Res 2008 0.96
7 Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency. Int J Cancer 2013 0.90
8 Definition and characterization of an inhibitor for interleukin-31. J Biol Chem 2010 0.88
9 Structural and functional evidence for a substrate exclusion mechanism in mammalian tolloid like-1 (TLL-1) proteinase. FEBS Lett 2009 0.86
10 A complete domain structure of Drosophila tolloid is required for cleavage of short gastrulation. J Biol Chem 2006 0.80
11 Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity. PLoS One 2013 0.80
12 Modulation of inflammation by Cicaderma ointment accelerates skin wound healing. J Pharmacol Exp Ther 2012 0.79
13 Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI. AIDS 2011 0.76
14 Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse. MAbs 2014 0.76